KUALA LUMPUR, Jan 22 — Only 51 cases (5.2 per cent) of 984 Adverse Event Following Immunisation cases for COVID-19 vaccine booster shots, which is equal to a rate of 0.005 reports for every 1,000 doses, are classified as serious as of Jan 20.
Health director-general Tan Sri Dr Noor Hisham Abdullah said overall, the National Pharmaceutical Regulatory Agency’s (NPRA) AEFI Division’s reporting system received 24,111 AEFI reports, including 984 reports involving booster doses.
“Monitoring of AEFI reports received by the NPRA so far concluded that the trend and rate of AEFI reporting relating to booster doses did not show any increase from what was seen during the administration of the primer doses.
“The same reporting trend has been reported by other countries conducting COVID-19 booster doese immunisation programmes,” he said in a statement today.
He said fever, pain at the injection site, headaches and fatigue were among the more common adverse effects reported by vaccine recipients.
Vaccine recipients who have adverse effects can make an AEFI report through notification on the MySejahtera app for effects listed in the app in addition to filing an online report by filling in a form such as Consumer Side Effect Reporting Form (ConSERF) at the NPRA website (www.npra.gov.my).
Meanwhile, Dr Noor Hisham said new COVID-19 cases reported today rose to 4,116 compared to 4,046 yesterday, bringing the total of infections to 2,829,089 as of noon today.
From that total, 39 cases (o.9 per cent) were category three, four and five while 4,077 cases (99.1 per cent) were category one and two.
“A total of 498 cases were import cases while 3,618 were local cases. 141 cases required intensive care treatment while 62 cases needed respiratory support,” he added.
There were 2,858 recoveries today, bringing the total to 2,753,119 recoveries overall. Also, nine new clusters were recorded, with 225 clusters still active.